Indications For Use - ResMed Lumis 100 VPAP ST User Manual

ENGLISH
Welcome
The Lumis 100 VPAP ST and Lumis 150 VPAP ST are bilevel positive airway pressure devices.
™
WARNING
• Read this entire guide before using the device.
• Use the device according to the intended use provided in this guide.
• The advice provided by your prescribing doctor should be followed ahead of the
information provided in this guide.
• This device is not suitable for ventilator-dependent patients.

Indications for use

Lumis 100 VPAP ST
The Lumis 100 VPAP ST device is indicated to provide non-invasive ventilation for patients weighing
more than 13 kg with respiratory insufficiency or obstructive sleep apnoea (OSA). It is intended for
home and hospital use.
The humidifier is intended for single patient use in the home environment and re-use in a
hospital/institutional environment.
Lumis 150 VPAP ST
The Lumis 150 VPAP ST device is indicated to provide non-invasive ventilation for patients weighing
more than 13 kg or more than 30 kg in iVAPS mode with respiratory insufficiency or obstructive
sleep apnoea (OSA). It is intended for home and hospital use.
The humidifier is intended for single patient use in the home environment and re-use in a
hospital/institutional environment.
Clinical benefits
The clinical benefit of CPAP and bilevel therapy for the treatment of OSA is a reduction in apnoeas,
hypopnoeas and sleepiness, as well as improved quality of life.
The clinical benefits of bilevel therapy for the treatment of respiratory insufficiency may include;
improvement in overall survival, daytime symptoms, blood gases, health-related quality of life and
sleep quality, and a decrease in hospitalisations and dyspnoea.
The clinical benefit of humidification is the reduction of positive airway pressure related side effects.
Intended patient population/medical conditions
Obstructive pulmonary diseases (eg, Chronic Obstructive Pulmonary Disease), restrictive pulmonary
diseases (eg, diseases of the lung parenchyma, diseases of the chest wall, neuromuscular
diseases), central respiratory regulation diseases, obstructive sleep apnoea (OSA) and obesity
hypoventilation syndrome (OHS).
English 1